Effects of the H(3) receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions.
[en] RATIONALE: Previous studies have shown that intraperitoneal injections of thioperamide, an imidazole-based H(3) receptor inverse agonist that enhances histamine release in the brain, potentiate cocaine-induced hyperlocomotion. The present study examined the involvement of the histaminergic system in these effects of thioperamide in mice. MATERIALS AND METHODS: We investigated whether immepip, a selective H(3) agonist, could reverse the potentiating effects of thioperamide. Moreover, the non-imidazole H(3) inverse agonist A-331440 was tested on the locomotor effects of cocaine. Using high-performance liquid chromatography with ultraviolet detection, cocaine plasma concentrations were measured to study potential drug-drug interactions between thioperamide and cocaine. Finally, thioperamide was tested on the locomotor effects of cocaine in histamine-deficient knockout mice in order to determine the contribution of histamine to the modulating effects of thioperamide. RESULTS: Thioperamide potentiated cocaine-induced hyperlocomotion in normal mice, and to a higher extent, in histamine-deficient knockout mice. A-331440 only slightly affected the locomotor effects of cocaine. Immepip did not alter cocaine-induced hyperactivity but significantly reduced the potentiating actions of thioperamide on cocaine's effects. Finally, plasma cocaine concentrations were more elevated in mice treated with thioperamide than in mice that received cocaine alone. CONCLUSIONS: The present results indicate that histamine released by thioperamide through the blockade of H(3) autoreceptors is not involved in the ability of this compound to potentiate cocaine induced-hyperactivity. Our data suggest that thioperamide, at least at 10 mg/kg, increases cocaine-induced locomotion through the combination of pharmacokinetic effects and the blockade of H(3) receptors located on non-histaminergic neurons.
Research Center/Unit :
Centre de Neurosciences Cognitives et Comportementales - ULiège
Brabant, Christian ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie humaine et pathologique
Alleva, Livia ; Université de Liège - ULiège > Département des sciences cognitives > Neuroscience comportementale et psychopharmacologie expér.
Grisar, Thierry ; Centre Hospitalier Universitaire de Liège - CHU > Neurologie Sart Tilman
Quertemont, Etienne ; Université de Liège - ULiège > Département des sciences cognitives > Psychologie quantitative
Lakaye, Bernard ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie humaine et pathologique
Ohtsu, Hiroshi; Tohoku University > Department of Quantum Science and Energy Engineering
Lin, Jian-Sheng; Université Claude Bernard - Lyon 1 - UCLB > Département de Médecine Expérimentale
Jatlow, Peter; Yale University > Department of Laboratory Medicine
Picciotto, Marina R; Yale University > Department of Psychiatry
Tirelli, Ezio ; Université de Liège - ULiège > Département des sciences cognitives > Neuroscience comportementale et psychopharmacologie expér.
Language :
English
Title :
Effects of the H(3) receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions.
Publication date :
2009
Journal title :
Psychopharmacology
ISSN :
0033-3158
eISSN :
1432-2072
Publisher :
Springer Verlag, Berlin, Germany
Volume :
202
Issue :
4
Pages :
673-87
Peer reviewed :
Peer Reviewed verified by ORBi
Funders :
F.R.S.-FNRS - Fonds de la Recherche Scientifique NIH - National Institutes of Health
M Akhtar DP Uma A Ali KK Pillai D Vohora 2006 Antipsychotic-like profile of thioperamide, a selective H3-receptor antagonist in mice Fundam Clin Pharmacol 20 373 378
A Alves-Rodrigues R Leurs TS Wu GD Prell C Foged H Timmerman 1996 [3H]-thioperamide as a radioligand for the histamine H3 receptor in rat cerebral cortex Br J Pharmacol 118 2045 52
JM Arrang M Garbarg JC Schwartz 1983 Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor Nature 302 832 837
A Borgkvist G Fisone 2007 Psychoactive drugs and regulation of the cAMP/PKA/DARPP-32 cascade in striatal medium spiny neurons Neurosci Biobehav Rev 31 79 88
C Brabant Y Charlier E Quertemont E Tirelli 2005 The H3 antagonist thioperamide reveals conditioned preference for a context associated with an inactive small dose of cocaine in C57BL/6J mice Behav Brain Res 160 161 168
C Brabant E Quertemont E Tirelli 2006 Effects of the H 3-receptor inverse agonist thioperamide on the psychomotor effects induced by acutely and repeatedly given cocaine in C57BL/6J mice Pharmacol Biochem Behav 83 561 569
Brabant C, Grisar T, Quertemont E, Lakaye B, Lin JS, Ohtsu H, Brunzell DH, Tirelli E (2007a) Examination of the role of H3 receptors in the locomotor effects of cocaine. Abstract from the Society for Neuroscience, San Diego, CA, USA
C Brabant E Quertemont C Anaclet JS Lin H Ohtsu E Tirelli 2007 The psychostimulant and rewarding effects of cocaine in histidine decarboxylase knockout mice do not support the hypothesis of an inhibitory function of histamine on reward Psychopharmacology 190 251 263
RE Brown DR Stevens HL Haas 2001 The physiology of brain histamine Prog Neurobiol 63 637 672
VC Campbell TA Kopajtic AH Newman JL Katz 2005 Assessment of the influence of histaminergic actions on cocaine-like effects of 3alpha-diphenylmethoxytropane analogs J Pharmacol Exp Ther 315 631 640
KE Cannon R Leurs LB Hough 2007 Activation of peripheral and spinal histamine H3 receptors inhibits formalin-induced inflammation and nociception, respectively Pharmacol Biochem Behav 88 122 9
S Chiavegatto AG Nasello MM Bernardi 1998 Histamine and spontaneous motor activity: biphasic changes, receptors involved and participation of the striatal dopamine system Life Sci 62 1875 1888
J Clapham GJ Kilpatrick 1994 Thioperamide, the selective histamine H 3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse Eur J Pharmacol 259 107 114
C Ferrada S Ferré V Casadó A Cortés Z Justinova C Barnes EI Canela SR Goldberg R Leurs C Lluis R Franco 2008 Interactions between histamine H(3) and dopamine D(2) receptors and the implications for striatal function Neuropharmacology 55 190 197
AE Fleckenstein KJ Lookingland KE Moore 1993 Activation of mesolimbic dopaminergic neurons following central administration of histamine is mediated by H1 receptors Naunyn-Schmiedeberg's Arch Pharmacol 347 50 54
Glantz S (1997) A primer of biostatistics (4th edition). McGraw-Hill, New York
RE Goodchild JA Court I Hobson MA Piggott RH Perry P Ince E Jaros EK Perry 1999 Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases Eur J Neurosci 11 449 456
AA Hancock ME Brune 2005 Assessment of pharmacology and potential anti-obesity properties of H3 receptor antagonists/inverse agonists Expert Opin Investig Drugs 14 223 41
AA Hancock YL Bennani EN Bush TA Esbenshade R Faghih GB Fox P Jacobson V Knourek-Segel KM Krueger ME Nuss JB Pan R Shapiro DG Witte BB Yao 2004 Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist Eur J Pharmacol 487 183 97
M Humbert-Claude S Morisset F Gbahou JM Arrang 2007 Histamine H 3 and dopamine D2 receptor-mediated [35 S]GTPgamma[S] binding in rat striatum: evidence for additive effects but lack of interactions Biochem Pharmacol 73 1172 1181
S Ikemoto 2007 Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex Brain Res Rev 56 27 78
Y Itoh M Nishibori R Oishi K Saeki 1984 Neuronal histamine inhibits methamphetamine-induced locomotor hyperactivity in mice Neurosci Lett 48 305 309
Y Itoh R Oishi M Nishibori K Saeki 1991 Characterization of histamine release from the rat hypothalamus as measured by in vivo microdialysis J Neurochem 56 769 774
P Jatlow H Nadim 1990 Determination of cocaine concentrations in plasma by high-performance liquid chromatography Clin Chem 36 1436 1439
PW Kalivas 1982 Histamine-induced arousal in the conscious and pentobarbital-pretreated rat J Pharmacol Exp Ther 222 37 42
Y Kubota C Ito E Sakurai E Sakurai T Watanabe H Ohtsu 2002 Increased methamphetamine-induced locomotor activity and behavioral sensitization in histamine-deficient mice J Neurochem 83 837 845
Y Lamberty DG Margineanu D Dassesse H Klitgaard 2003 H3 agonist immepip markedly reduces cortical histamine release, but only weakly promotes sleep in the rat Pharmacol Res 48 193 198
D Leibman A Smolen T Smolen 1990 Strain, sex and developmental profiles of cocaine metabolizing enzymes in mice Pharmacol Biochem Behav 37 161 165
D Moreno-Delgado A Torrent J Gómez-Ramírez I de Esch I Blanco J Ortiz 2006 Constitutive activity of H3 autoreceptors modulates histamine synthesis in rat brain through the cAMP/PKA pathway Neuropharmacology 5 517 23
T Mori M Narita K Onodera T Suzuki 2002 Modulation of the discriminative stimulus effects of cocaine and methamphetamine by the histaminergic system Jpn J Neuropsychopharmacol 22 73 78
S Morisset A Rouleau X Ligneau F Gbahou J Tardivel-Lacombe H Stark W Schunack CR Ganellin JC Schwartz JM Arrang 2000 High constitutive activity of native H3 receptors regulates histamine neurons in brain Nature 408 860 864
S Morisset C Pilon J Tardivel-Lacombe D Weinstein W Rostene C Betancur P Sokoloff JC Schwartz JM Arrang 2002 Acute and chronic effects of methamphetamine on tele-methylhistamine levels in mouse brain: selective involvement of the D(2) and not D(3) receptor J Pharmacol Exp Ther 300 621 628
P Munzar R Nosal SR Goldberg 1998 Potentiation of the discriminative-stimulus effects of methamphetamine by the histamine H 3 receptor antagonist thioperamide in rats Eur J Pharmacol 363 93 101
P Munzar G Tanda Z Justinova SR Goldberg 2004 Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release Neuropsychopharmacology 29 705 717
H Ohtsu S Tanaka T Terui Y Hori Y Makabe-Kobayashi G Pejler E Tchougounova 2001 Mice lacking histidine decarboxylase exhibit abnormal mast cells FEBS Lett 502 53 56
P Panula U Pirvola S Auvinen MS Airaksinen 1989 Histamine-immunoreactive nerve fibers in the rat brain Neuroscience 28 585 610
P Pellinen P Honkakoski F Stenback M Niemitz E Alhava O Pelkonen MA Lang M Pasanen 1994 Cocaine N-demethylation and the metabolism-related hepatotoxicity can be prevented by cytochrome P450 3A inhibitors Eur J Pharmacol 270 35 43
P Pellinen L Kulmala J Konttila S Auriola M Pasanen R Juvonen 2000 Kinetic characteristics of norcocaine N-hydroxylation in mouse and human liver microsomes: involvement of CYP enzymes Arch Toxicol 74 511 520
TS Poet CA McQueen JR Halpert 1996 Participation of cytochromes P4502B and P4503A in cocaine toxicity in rat hepatocytes Drug Metab Dispos 24 74 80
H Pollard J Moreau JM Arrang JC Schwartz 1993 A detailed autoradiographic mapping of histamine H3 receptors in rat brain areas Neuroscience 52 169 189
JH Ryu K Yanai R Iwata T Ido T Watanabe 1994 Heterogeneous distributions of histamine H3, dopamine D1 and D2 receptors in rat brain Neuroreport 5 621 4
E Sanchez-Lemus JA Arias-Montano 2004 Histamine H3 receptor activation inhibits dopamine D1 receptor-induced cAMP accumulation in rat striatal slices Neurosci Lett 364 179 184
JC Schwartz JM Jean-Michel Arrang M Garbarg 1986 Three classes of histamine receptors Trends Pharmacol Sci 7 24 28
SJ Taylor AD Michel GJ Kilpatrick 1992 In vivo occupancy of histamine H3 receptors by thioperamide and (R)-alpha-methylhistamine measured using histamine turnover and an ex vivo labeling technique Biochem Pharmacol 44 1261 7
R Yang JA Hey R Aslanian CA Rizzo 2002 Coordination of histamine H 3 receptor antagonists with human adrenal cytochrome P450 enzymes Pharmacology 66 128 135
M Zhang ME Ballard L Pan S Roberts R Faghih M Cowart TA Esbenshade GB Fox MW Decker AA Hancock LE Rueter 2005 Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs Brain Res 1045 142 149
